Skip to main content
. 2016 Nov 30;14(4):345–350. doi: 10.9758/cpn.2016.14.4.345

Fig. 2.

Fig. 2

Plasma malondialdehyde (MDA) levels of overall schizophrenia patients and controls were 5.4±2.7 nmol/mL and 3.9±1.8 nmol/ml, respectively; p=0.001.